News

NBCA Educational Materials Selected for Use in New Joint Commission Educational Effort

The National Blood Clot Alliance is honored to have its website, as well as several of its …

Read the full story
FDA Approved

FDA Approves Andexxa®

NEW DRUG APPROVAL: The U.S. Food & Drug Administration (FDA) has granted Portola …

Read the full story

May e-Newsletter | Celebrate & Share During National Women’s Health Week

Join the National Blood Clot Alliance (NBCA) during National Women’s Health Week (NWHW), May …

Read the full story

Celebrate & Share During National Women’s Health Week

Birth Control and Blood Clots: Know Your Risk There are more than 60 million women of …

Read the full story

New Thrombophilia Resource

NBCA recently updated information on its website about thrombophilia or genetic blood clotting …

Read the full story

April e-Newsletter | Sharing our Success

We at NBCA are always inspired by your enthusiasm for the work that we do, but never more so …

Read the full story

MASAB Memo, April 2018

MASAB Memo #6, April 16, 2018 The HOKUSAI VTE Cancer Study by Michael Streiff, MD, Professor of …

Read the full story

New Patient Preference Survey

Several hundred NBCA Facebook Followers participated in an online survey conducted by …

Read the full story

March e-Newsletter | Blood Clot Awareness Month

March is Blood Clot Awareness Month, or BCAM, and an opportunity to share life-saving …

Read the full story

MASAB Memo, March 2018

MASAB Memo #5, March 7, 2018 New Study Results – Clot-Busting Treatment by Suresh …

Read the full story